About Doctolib
Founded in 2013 by Stanislas Niox-Chateau and co-founders, Doctolib is one of Europe’s leading health technology platforms. It supports tens of thousands of healthcare professionals and millions of patients across France, Germany, Italy and other markets throughout Europe, with its services spanning online appointment booking, telehealth consultations and patient communications.
In 2022, the company raised €500m in a mix of equity and debt, led by Eurazeo with participation from Bpifrance and General Atlantic, bringing its valuation to $6.4bn, at the time the highest for a French startup. Doctolib remains backed by venture capital and growth-oriented equity, and its valuation, funding and expansion into new product verticals have reinforced its position as a top-tier e-health unicorn.